Papalexi, Eugenia
Galanopoulos, Andreas
Kontis, Dimitrios
Markopoulou, Maria
Balta, Georgia
Karavelas, Evaggelos
Panagiotidis, Panagiotis
Vlachos, Themistoklis
Ettrup, Anders
Funding for this research was provided by:
Lundbeck Hellas
Article History
Received: 16 November 2021
Accepted: 29 June 2022
First Online: 12 August 2022
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. All experimental protocols were approved by the institutional review boards at the two coordinating hospitals (Psychiatric Hospital of Attica and Psychiatric Hospital of Thessaloniki). At the time the study was conducted, ethical approval for observational studies was not required at a national level. All patients provided written informed consent for participation.
: Not applicable.
: E.P. and A.G. are employees of Lundbeck Hellas. A.E. is an employee of H. Lundbeck A/S. D.K., M.M., G.B., E.K., P.P., and T.V. received research funding (to their respective institutions) from Lundbeck Hellas. D.K. has also received support for participation in conferences from Lilly and Janssen and honoraria as a speaker from Janssen. M.M. has also received support for participation in conferences from Lundbeck Hellas, Janssen Cilag, Pfizer, Innovis, and Anabiosis Pharmaceuticals, and honoraria as a speaker from Lundbeck Hellas and Janssen Cilag. G.B., E.K., P.P., and T.V. report no other competing interests.